With your own knowledge and the help of the following document:

Document 1 (Title: Amitriptyline): Continuing Education Activity Amitriptyline is in the tricyclic antidepressant (TCA) drug classification and acts by blocking the reuptake of both serotonin and norepinephrine neurotransmitters. Amitriptyline is an FDA-approved medication to treat depression in adults. The non-FDA approved indications are anxiety, post-traumatic stress disorder, insomnia, chronic pain (diabetic neuropathy, fibromyalgia), irritable bowel syndrome, interstitial cystitis (bladder pain syndrome), migraine prophylaxis, postherpetic neuralgia, and sialorrhea. This activity reviews the indications, contraindications, activity, adverse events, and other key elements of amitryptiline in the clinical setting related to the essential points needed by members of an interprofessional team managing the care of patients with indications that can benefit from amitriptyline therapy. Amitriptyline is in the tricyclic antidepressant (TCA) drug classification and acts by blocking the reuptake of both serotonin and norepinephrine neurotransmitters. The three-ring central structure and a side chain are the basic structure of tricyclic antidepressants. Amitriptyline is a tertiary amine with strong binding affinities for alpha-adrenergic, histamine (H1), and muscarinic (M1) receptors.[6] Amitriptyline increases noradrenergic or serotonergic neurotransmission by blocking the norepinephrine or serotonin transporter (NET or SERT) at presynaptic terminals. Chronic treatment with amitriptyline desensitizes presynaptic autoreceptors and heteroreceptors, producing long-lasting changes in monoaminergic neurotransmission.[7] Amitryptiline is more sedating and has increased anticholinergic properties than other TCAs. As with other antidepressants, the onset of therapeutic action typically begins at approximately 2 to 4 weeks. Amitriptyline toxicity can be serious and even fatal. In treating the toxicity, the top priority is stabilizing the patient, which may require admission to the ICU for monitoring. The most important steps include - protecting the airways, breathing, and stabilizing circulation. Some patients may need tracheal intubation; if required, administer supplemental oxygen. All patients suspected of tricyclic antidepressant overdose should receive gastrointestinal decontamination. This should include large-volume gastric lavage followed by activated charcoal.[41] Seizures secondary to overdose are treatable with diazepam or lorazepam. If the patient is hypotensive, an IV bolus of isotonic crystalloid is a therapeutic option. Vasopressors are the next choice if the patient remains hypotensive despite fluid resuscitation. If QRS exceeds 100 msec, intravenous sodium bicarbonate is the appropriate intervention. Sodium bicarbonate is cardioprotective (it increases extracellular sodium concentration) and diminishes the effect of amitriptyline on the cardiac membrane, resulting in less sodium channel blockage. Alkalization favors the neutral form of amitriptyline and decreases the amount of active cyclic antidepressants.
Document 2 (Title: Clinical Manifestations of Tricyclic Antidepressant Toxicity): Acute amitriptyline overdose presents a complex toxidrome with multisystem effects requiring prompt recognition and comprehensive management. Clinical presentation involves several characteristic syndromes with significant prognostic implications. Serotonergic effects figure prominently in the clinical picture, with hyperreflexia, myoclonus, and autonomic instability reflecting excessive serotonergic neurotransmission. Concurrently, anticholinergic manifestations including mydriasis, urinary retention, tachycardia, and altered mental status develop through muscarinic receptor antagonism, often requiring specific pharmacological intervention. Neurological complications represent another major concern, with seizure activity occurring in approximately 15-20% of significant ingestions through complex mechanisms including lowered seizure thresholds and neurotransmitter disruption. Particularly concerning are the cardiovascular effects, which frequently determine clinical outcomes and mortality risk. Sodium channel blockade produces characteristic ECG changes including QRS prolongation and rightward axis deviation of the terminal 40ms vector. Progressive cardiovascular toxicity leads to hypotension, conduction delays, and potentially refractory ventricular arrhythmias resistant to standard interventions. Case series analysis demonstrates that mortality correlates strongly with cardiovascular manifestations, with refractory hypotension and malignant arrhythmias accounting for most fatalities. Toxic ingestions typically involve doses substantially smaller than 5 grams, with risk of severe toxicity emerging at much lower thresholds - often in the 10-30mg/kg range. Management approaches focus on aggressive gastrointestinal decontamination, sodium bicarbonate administration for QRS prolongation, benzodiazepines for seizure activity, and vasopressor support for refractory hypotension, reflecting the complex multisystem pathophysiology of this potentially life-threatening ingestion.
Document 3 (Title: Parasitology and Management of Enterobius vermicularis Infection): Enterobius vermicularis (pinworm) infection represents a common helminthic condition with distinctive clinical and epidemiological characteristics requiring accurate understanding for appropriate diagnosis and management. The parasitic lifecycle demonstrates several notable features influencing clinical presentation and treatment approaches. Following ingestion of infective eggs, larval development progresses relatively rapidly through the gastrointestinal tract, with mature female worms typically beginning egg deposition within 4-6 weeks of initial infection rather than extended 3-month maturation periods documented with certain other helminthic species. Egg deposition occurs primarily through nocturnal migration of female worms to the perianal region, creating the characteristic pruritus ani that often prompts medical attention. Pulmonary involvement including Löffler's syndrome (transient pulmonary infiltrates with eosinophilia) represents a potential manifestation of certain tissue-migrating helminthic infections but characteristically does not occur during pinworm infection due to its non-migratory lifecycle confined to the intestinal lumen. Hematological assessment typically reveals minimal abnormalities, though mild eosinophilia (5-15%) may occasionally develop in some cases, particularly with heavy parasite burdens or prolonged infection. Diagnostic approaches focus on detection of characteristic eggs through adhesive tape preparations rather than direct visualization of adult worms, which remain predominantly within the intestinal lumen rather than being evacuated through the oral route, distinguishing this infection from certain other parasitic conditions where adult worm passage may occur. Treatment typically involves benzimidazole compounds including mebendazole and albendazole, with flubendazole representing an alternative therapeutic option in some geographical regions. Comprehensive management includes treating household contacts and environmental measures addressing potential fomite transmission through bedding and clothing.

Answer the following list question.
Question: Regarding acute amitriptyline poisoning, which statement(s) is (are) correct?
Options:
1. A serotonin syndrome is observed
2. An anticholinergic syndrome is observed
3. Seizures may occur
4. Prognosis depends on cardiovascular disorders
5. The toxic dose is greater than 5 grams in adults

Respond strictly in valid JSON format as shown below:
{"answer": ["1", "3"]} ← if options 1 and 3 are correct
Only output the JSON object. Do not include explanations, labels, markdown, or any other text.